Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Philomine A, van Pelt"'
Autor:
Kim, van Slingerland, Margot J M, Walter, Heleen A, van der Stege, AnneLoes, van Staa, Philomine A, van Pelt, Pascal H P, de Jong
Publikováno v:
Journal of the American Association of Nurse Practitioners, 34(8), 963-967. John Wiley & Sons Ltd.
Background:Health care is shifting toward a person-centered care (PCC) approach. For implementation of PCC, there may be a special role for nurse practitioners (NPs).Purpose:The aim of this study was to explore the patient-perceived levels of and nee
Autor:
Nicolino Ruperto, Sebastiaan J. Vastert, Francesca Bovis, Joost F Swart, Sylvia Kamphuis, Philomine A van Pelt, Annette van Dijk-Hummelman, Nico M Wulffraat, Alessandro Consolaro, Pieter Van Dijkhuizen
Publikováno v:
Rheumatology International, 38(suppl 1), 139. Springer Verlag
Rheumatology International
Rheumatology International, 38, 139-146. Springer-Verlag
Rheumatology International
Rheumatology International, 38, 139-146. Springer-Verlag
textabstractThe Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report th
Autor:
Lisette W A van Suijlekom-Smit, J. Anink, Maryanne Dijkstra, Philomine A van Pelt, Johanna M. W. Hazes
Publikováno v:
Journal of Rheumatology, 42(3), 527-533. Journal of Rheumatology
Objective.To evaluate the reliability of a manikin format, patient-reported joint count in juvenile idiopathic arthritis (JIA), and to detect changes in agreement at a second visit.Methods.Patients with JIA aged 12–21 were asked to mark joints with
Autor:
Marco van Brussel, Radboud J E M Dolhain, Jwj Bijlsma, NM Wulffraat, J. M. W. Hazes, Tim Takken, Aike A. Kruize, Philomine A van Pelt
Publikováno v:
Poster Presentations.
Background Aerobic fitness may serve as an important health-related outcome measure in JIA. A reduced aerobic fitness is associated with cardiovascular morbidity, mortality and osteoporosis in adult patients with chronic diseases. However, in adolesc
Autor:
Kirsten Minden, Simon Stones, Berna Eren Fidanci, Rachel Tattersall, Karin Berggren, Jennifer M Waite-Jones, Ruth Wyllie, Loreto Carmona, Carine Wouters, Helen E. Foster, Janet E. McDonagh, Tamás Constantin, Daniel Clemente, Leticia Leon, Philomine A van Pelt, Sylvia Kamphuis, Susanne Schalm, Seza Ozen, Burak Erer, Alberto Martini, Erkan Dermikaya
Publikováno v:
Foster, H, Minden, K, Clemente, D, Leon, L, McDonagh, J E, Kamphuis, S, Berggren, K, van Pelt, P, Wouters, C, Waite-Jones, J, Tattersall, R, Wyllie, R, Stones, S R, Martini, A, Constantin, T, Schalm, S, Fidanci, B, Erer, B, Demirkaya, E, Ozen, S & Carmona, L 2017, ' EULAR / PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2016-210112
Annals of the Rheumatic Diseases, 76(4). BMJ Publishing Group
Annals of the Rheumatic Diseases, 76(4). BMJ Publishing Group
Aims. To develop standards and recommendations for transitional care for young people (YP) with juvenile onset rheumatic and musculoskeletal diseases (jRMD). Methods. The consensus process involved the following: 1) Establishing an international expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c8b67a6f85346f49d9b0d0a83b55d3
https://doi.org/10.1136/annrheumdis-2016-210112
https://doi.org/10.1136/annrheumdis-2016-210112
Autor:
Hans W J Bijlsma, Harmieke van Os-Medendorp, Lieske Scholtus, Nienke C. de Boer-Nijhof, Aike A. Kruize, Philomine A van Pelt, Judy W. Ammerlaan, Berent J. Prakken
Publikováno v:
Pediatric Rheumatology, 15:75. BioMed Central Ltd.
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-13 (2017)
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-13 (2017)
Background A web-based self-management intervention guided by peer-trainers was developed to support young adults’ self-management in coping with Juvenile Idiopathic Arthritis (JIA). To investigate its effectiveness, a randomized controlled trial (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa24b52a84e39b782a9e9d897a4f857
https://pure.eur.nl/en/publications/401e0efd-b445-4e26-a728-b548319fae44
https://pure.eur.nl/en/publications/401e0efd-b445-4e26-a728-b548319fae44
Autor:
Philomine A, van Pelt, Radboud J E M, Dolhain, Aike A, Kruize, Judy J W, Ammerlaan, Johanna W, Hazes, Johannes W J, Bijlsma, Nico M, Wulffraat
Publikováno v:
Clinical and experimental rheumatology. 36(1)
Reaching a certain age, juvenile idiopathic arthritis (JIA) patients in paediatric care are transferred to adult care. An increased disease activity after transfer and increased dropout has been suggested, however, evidence is scarce. Our aim is to d
Autor:
Esther P A H Hoppenreijs, Wineke Armbrust, Femke H M Prince, Lisette W A van Suijlekom-Smit, Rebecca ten Cate, Marion A J van Rossum, Marieke H Otten, Y. Koopman-Keemink, J. Merlijn van den Berg, Joost F Swart, Philomine A van Pelt, Simone L Gorter, Nico M Wulffraat, Koert M. Dolman, Sylvia Kamphuis, Janneke Anink
Publikováno v:
Rheumatology, 52(4), 712-717
Rheumatology, 52, 4, pp. 712-7
Rheumatology, 52, 712-7
Rheumatology, 52(4), 712-717. Oxford University Press
Rheumatology, 52, 712-717. Oxford University Press
Rheumatology (Oxford, England), 52(4), 712-717. Oxford University Press
Rheumatology, 52, 4, pp. 712-7
Rheumatology, 52, 712-7
Rheumatology, 52(4), 712-717. Oxford University Press
Rheumatology, 52, 712-717. Oxford University Press
Rheumatology (Oxford, England), 52(4), 712-717. Oxford University Press
Item does not contain fulltext Objective. Because TNF inhibitors are not approved for persistent oligoarticular JIA (oJIA), although they are used off-label, we evaluated their effectiveness in patients in this category. Methods. Persistent oJIA pati
Autor:
Rebecca ten Cate, Simone L Gorter, Wijnand A. A. Swen, Joost F Swart, Janneke Anink, Marion A J van Rossum, Nico M Wulffraat, Lisette W A van Suijlekom-Smit, Koert M. Dolman, Philomine A van Pelt, Danielle M.C. Brinkman, J. Merlijn van den Berg, Marieke H Otten, Sylvia Kamphuis, Wineke Armbrust, Y. Koopman-Keemink, Femke H M Prince, Esther P A H Hoppenreijs
Publikováno v:
Rheumatology, 52, 9, pp. 1674-9
Rheumatology, 52(9), 1674-1679
Rheumatology, 52, 1674-9
Rheumatology, 52(9), 1674-1679. Oxford University Press
Rheumatology (Oxford, England), 52(9), 1674-1679. Oxford University Press
Rheumatology, 52(9), 1674-1679
Rheumatology, 52, 1674-9
Rheumatology, 52(9), 1674-1679. Oxford University Press
Rheumatology (Oxford, England), 52(9), 1674-1679. Oxford University Press
Item does not contain fulltext Objectives. To evaluate differences in baseline characteristics between etanercept- and adalimumab-treated JIA patients and to reveal factors that influence the choice between these TNF inhibitors, which are considered
Autor:
Rebecca ten Cate, Marion A J van Rossum, Koert M. Dolman, Y. Koopman-Keemink, Esther P A H Hoppenreijs, Femke H M Prince, Simone L Gorter, Janneke Anink, Marieke H Otten, J. Merlijn van den Berg, Nico M Wulffraat, Joost F Swart, Wineke Armbrust, Lisette W A van Suijlekom-Smit, Philomine A van Pelt, Sylvia Kamphuis
Publikováno v:
Annals of the Rheumatic Diseases, 72(5), 721-727
Annals of the rheumatic diseases, 72(5), 721-727. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 721-727. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 721-7
Annals of the Rheumatic Diseases, 72, 5, pp. 721-7
Annals of the Rheumatic Diseases, 72(5), 721-727. BMJ PUBLISHING GROUP
Annals of the rheumatic diseases, 72(5), 721-727. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 721-727. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 721-7
Annals of the Rheumatic Diseases, 72, 5, pp. 721-7
Annals of the Rheumatic Diseases, 72(5), 721-727. BMJ PUBLISHING GROUP
Item does not contain fulltext OBJECTIVE: To evaluate the effectiveness and safety of switching to a second or third biological agent in juvenile idiopathic arthritis (JIA) after etanercept failure. METHODS: The Arthritis and Biologicals in Children